This compound is a pharmaceutical intermediate consisting of a tert-butyl carbamate-protected amino alcohol combined with succinic acid as a salt-forming agent. It is used in research and manufacturing settings for the synthesis of more complex active pharmaceutical ingredients.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 169870-02-4
Bdh succinate
Pharmaceutical intermediate for HIV protease inhibitors
Carbamic acid, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester
Pharmaceutical intermediate for peptide synthesis
Methyl 4,4'-biphenyl-R-alanate
Pharmaceutical intermediate for drug synthesis
(4'-Methyl-3-fluoro[1,1'-biphenyl]-4-yl)-boronic acid
pharmaceutical intermediate
(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-1-yl)hexanoate
Calcitriol intermediate
2,4-Dichloro-6-phenyl-1,3,5-triazine
Pharmaceutical intermediate
(3-(6-Phenylhexyl)phenyl)boronic acid
n.a
1,6-Diphenylhexane
n.a
butanedioic acid;tert-butyl N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate
ZICUGSIJUKRRJL-OCIDDWSYSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.C(CC(=O)O)C(=O)O